Viking Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Viking Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viking Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viking Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $4.4M | 106k | 41.67 |
| 2025-12-31 | $4.8M | 91k | 52.63 |
| 2025-09-30 | $4.5M | 86k | 52.63 |
| 2025-06-30 | $4.1M | 78k | 52.63 |
| 2025-03-31 | $3.7M | 70k | 52.63 |
| 2024-12-31 | $2.4M | 61k | 40.25 |
| 2024-09-30 | $4.0M | 63k | 63.32 |
| 2024-06-30 | $3.2M | 60k | 53.03 |
| 2024-03-31 | $5.0M | 61k | 82.01 |
| 2023-12-31 | $1.0M | 55k | 18.61 |
| 2023-09-30 | $459k | 42k | 11.07 |
| 2023-06-30 | $739k | 46k | 16.22 |